uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Diseasekatrina4384Sep 21 min readhttps://uniqure.gcs-web.com/news-releases/news-release-details/uniqure-announces-submission-biologics-license-application
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec(AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
In Buckshot Roulette, I tried a more patient style instead of making bold moves every turn. It was interesting to see how much the atmosphere changed when I played that way.